-
Fomivirsen (brand name
Vitravene) is an
antisense antiviral drug that was used in the
treatment of
cytomegalovirus retinitis (CMV) in immunocompromised...
-
genomic medicine therapeutical intervention.
Fomivirsen (marketed as
Vitravene), was
approved by the U.S. FDA in
August 1998, as a
treatment for cytomegalovirus...
-
Akcea Therapeutics. The company's
first marketed drug was
fomivirsen (
Vitravene, used to
treat cytomegalovirus retinitis (CMV) in
immunocompromised patients)...
-
approved the
phosphorothioate antisense oligonucleotides fomivirsen (
Vitravene) and
mipomersen (Kynamro) for
human therapeutic use. In virology, the...
-
compounds are the
basis of
antisense therapy, e.g., the
drugs fomivirsen (
Vitravene), oblimersen, alicaforsen, and
mipomersen (Kynamro).
Further examples...
-
Vitamin K1
Vitaneed Vitaped Vitec Vitekta Vitrakvi Vitrase Vitrasert Vitravene Vitrax Vitussin Vituz Vivacaine Vivactil Vivelle-Dot
Vivelle Vivimusta...
- They are the
basis of
antisense therapy, e.g., the
drugs fomivirsen (
Vitravene), oblimersen, alicaforsen, and
mipomersen (Kynamro). The
simplest thiophosphates...
- use and not
applied in patients. It was
until 1998, that
fomivirsen (
Vitravene™), the
first intravitreal administered medication, was
approved by the...
- and the
European medicine agency (EMA) (1999) is
called Fomivirsen or
Vitravene. The
target organ is the eye and
works against the
cytomegalovirus (CMV)...
